Basic info
Industry
biotechnology research
Sectors
epilepsy
Biotechnology
pain
Health Care
clinical development
Pharmaceutical
depression
neurology
biotech
Date founded
2018
Funding rounds raised
Total raised
$80M
from 6 investors over 6 rounds
E
Eliem Therapeutics raised $60M on May 24, 2021
Investors: Intermediate Capital Group (ICG), RA Capital Management, L.P. and Samlyn Capital, LLC
E
Eliem Therapeutics raised $80M on March 25, 2021
Investors: Intermediate Capital Group (ICG) and RA Capital Management, L.P.
E
Eliem Therapeutics raised $16M on February 19, 2019
Investors: RA Capital Management, L.P.